← All organizations
Highest phase reached
Phase 4
First clinical trial
Sep 1, 2003Last known activity
Sep 30, 2025
Timeline
1960s
- Jan 1, 1963
Boryung Pharmaceutical Company— Founded
Drugs by trial phase (69 distinct, 128 trials)
Phase 4 (12 own, 0 via acquisition)
Phase 3 (26 own, 0 via acquisition)
Phase 2 (5 own, 0 via acquisition)
Phase 1 (26 own, 0 via acquisition)
Indications
Studied for
- Alzheimer Disease
- Anorexia
- Aortic Valve Stenosis
- Cachexia
- Candidiasis
- Carcinoma
- Cerebral Infarction
- Constriction, Pathologic
- Coronary Artery Disease
- Coronary Disease
- Dermatomycoses
- Diphtheria
- Dyslipidemias
- Encephalitis
- Encephalitis, Japanese
- Endometrial Neoplasms
- Esophagitis
- Essential Hypertension
- Fallopian Tube Neoplasms
- Hepatitis
- Hepatitis A
- Histoplasmosis
- Hyperlipidemias
- Hyperplasia
- Hypertension
- Inflammation
- Ischemia
- Kidney Diseases
- Leiomyoma
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Liver Diseases
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Non-Hodgkin
- Lymphoma, T-Cell, Peripheral
- Metabolic Syndrome
- Mycoses
- Myofibroma
- Ovarian Neoplasms
- Peptic Ulcer
- Peripheral Nervous System Diseases
- Peritoneal Neoplasms
- Plaque, Atherosclerotic
- Poliomyelitis
- Prostatic Hyperplasia
- Renal Insufficiency
- Renal Insufficiency, Chronic
- Sepsis
- Shock
- Shock, Septic
- Stomach Neoplasms
- Stomach Ulcer
- Stroke
- Syndrome
- Tetanus
- Tetany
- Toxemia
- Urinary Bladder, Overactive
- Uterine Cervical Neoplasms
- Waldenstrom Macroglobulinemia
- Whooping Cough
Recent trials (50)
- NCT07180771Lead sponsorPhase 2Sep 30, 2025
- NCT07083401Lead sponsorPhase 1Jul 5, 2025
- NCT07083388Lead sponsorPhase 1Jul 3, 2025
- NCT07069335Lead sponsorPhase 1Jun 17, 2025
- NCT06972732Lead sponsorPhase 4Jun 11, 2025
- NCT06821945Lead sponsorPhase 2May 30, 2025
- NCT06889012Lead sponsorPhase 1May 7, 2025
- NCT06867497Lead sponsorPhase 1Feb 24, 2025
- NCT06744439Lead sponsorPhase 1Jan 9, 2025
- NCT06744062Lead sponsorPhase 1Jan 5, 2025
- NCT06744426Lead sponsorPhase 1Jan 4, 2025
- NCT06744127Lead sponsorPhase 1Jan 3, 2025
- NCT06890299Lead sponsorPhase 1Dec 5, 2024
- NCT06890286Lead sponsorPhase 1Dec 1, 2024
- NCT06879158Lead sponsorPhase 1Nov 10, 2024
Details
- Founded
- Seoul, KR Jan 1, 1963
- Last known activity
- Sep 30, 2025